Page 30 - Product Testing News Today

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Florida Cancer Specialists & Research Institute Streamlines Sharing of Images and ... Florida Cancer SpecialistsMarch 12, 2021 GMT Fort Myers, Fla., March 12, 2021 (GLOBE NEWSWIRE) -- Florida Cancer Specialists has developed a best-in-class Cloud-based portal to enable the digital transfer of radiology images, reports and treatment plans among healthcare providers. Patient images and information can n...

Press release content from PR Newswire. The AP news staff was not involved in its creation. Johnson & Johnson Single-Shot COVID-19 Vaccine Granted Emergency Use Listing by the World Health Organization March 12, 2021 GMT (PRNewsfoto/Johnson & Johnson) NEW BRUNSWICK, N.J., March 12, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the World Health Organization (WHO) has issued Emergency Use Listing (EUL) for its single-shot COVID-19 vaccine, developed by the ...

Press release content from Business Wire. The AP news staff was not involved in its creation.

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Addex Reports Full Year 2020 Financial Results and Provides Corporate Update Addex TherapeuticsMarch 11, 2021 GMT Strong cash and cash equivalents position at Dec 31, 2020 of $20.2M (CHF18.7M) Balance sheet further strengthened by $11.5M fundraising on January 11, 2021 Three clinical studies in neurology programs expected to start during H1 2021 Clinical stage neurology programs aimed at large underse...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Immunocore Announces Upcoming Presentations at the American Association for Cancer Research ... Immunocore Holdings PlcMarch 11, 2021 GMT OXFORDSHIRE, England and CONSHOHOCKEN, Penn. and ROCKVILLE, Md., March 10, 2021 (GLOBE NEWSWIRE) -- Immunocore (Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed...

Press release content from Business Wire. The AP news staff was not involved in its creation. UVDI V-MAX™ UV-C Technology Proven to Eliminate 99.99% of Airborne SARS-CoV-2 in Moving Airstream HVAC Testing March 11, 2021 GMT UVDI UV-C Indoor Air Quality technology is installed in over 10,000 commercial buildings globally, including office buildings, airports, healthcare facilities and schools. (Photo: Business Wire) UVDI UV-C Indoor Air Quality technology is installed in over 10,000 commercial...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Clene Nanomedicine Announces Upcoming Presentations at the Maxim Group LLC Inaugural 2021 ... Clene Inc.March 10, 2021 GMT SALT LAKE CITY, March 10, 2021 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on the treatment of neurodegenerative disease using...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from Business Wire. The AP news staff was not involved in its creation. Humanigen Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update March 10, 2021 GMT BURLINGAME, Calif.--(BUSINESS WIRE)--Mar 10, 2021-- Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab™, today rep...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Merus Announces Poster Presentations for Zenocutuzumab and MCLA-129 at the American Association ... Merus N.V.March 10, 2021 GMT UTRECHT, The Netherlands and CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “the Company”, “we”, or “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® an...